Mesenchymal stem cells inhibited the inflammation and oxidative stress in LPS-activated microglial cells through AMPK pathway
- PMID: 31707461
- DOI: 10.1007/s00702-019-02102-z
Mesenchymal stem cells inhibited the inflammation and oxidative stress in LPS-activated microglial cells through AMPK pathway
Abstract
Microglia are the resident mononuclear immune cells of the central nervous system (CNS) and the activation of microglia contributes to the production of excessive neurotoxic factors. In particular, the overproduction of neurotoxic factors has critical effects on the development of brain injuries and neurodegenerative diseases. The human bone marrow-derived mesenchymal stem cells (hBM-MSCs) have blossomed into an effective approach with great potential for the treatment of neurodegenerative diseases and gliomas. The present study aimed to investigate the mechanism behind the therapeutic effect of hBM-MSCs on the activation of microglia in vitro. Specifically, the hBM-MSCs significantly inhibited the proliferation of lipopolysaccharide-activated microglial cells (LPS)-activated microglial cells. Additionally, we investigated whether the adenosine-monophosphate-activated protein kinase signaling (AMPK) pathway was involved in this process. Our data demonstrated that hBM-MSCs significantly increased the phosphorylated AMPK in LPS-activated microglial cells. In addition, our study indicated the inhibitory effect of hBM-MSCs on the pro-inflammatory mediators and oxidative stress by the AMPK pathway in LPS-activated microglial cells. These results could shed light on the understanding of the molecular basis for the inhibition of hBM-MSCs on LPS-activated microglial cells and provide a molecular mechanism for the hBM-MSCs implication in brain injuries and neurodegenerative diseases.
Keywords: Activated microglial cells; Adenosine-monophosphate-activated protein kinase; Bone marrow-derived mesenchymal stem cells.
Similar articles
-
Reciprocal interactions of mouse bone marrow-derived mesenchymal stem cells and BV2 microglia after lipopolysaccharide stimulation.Stem Cell Res Ther. 2013 Jan 28;4(1):12. doi: 10.1186/scrt160. Stem Cell Res Ther. 2013. PMID: 23356521 Free PMC article.
-
Bone marrow-derived mesenchymal stem cells maintain the resting phenotype of microglia and inhibit microglial activation.PLoS One. 2013 Dec 31;8(12):e84116. doi: 10.1371/journal.pone.0084116. eCollection 2013. PLoS One. 2013. PMID: 24391898 Free PMC article.
-
Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro.Stem Cell Res Ther. 2017 Apr 17;8(1):79. doi: 10.1186/s13287-017-0531-4. Stem Cell Res Ther. 2017. PMID: 28412968 Free PMC article.
-
Human Bone Marrow-Derived Mesenchymal Stem Cell Applications in Neurodegenerative Disease Treatment and Integrated Omics Analysis for Successful Stem Cell Therapy.Bioengineering (Basel). 2023 May 22;10(5):621. doi: 10.3390/bioengineering10050621. Bioengineering (Basel). 2023. PMID: 37237691 Free PMC article. Review.
-
Mechanisms of Inhibition of Excessive Microglial Activation by Melatonin.J Mol Neurosci. 2020 Aug;70(8):1229-1236. doi: 10.1007/s12031-020-01531-w. Epub 2020 Mar 28. J Mol Neurosci. 2020. PMID: 32222896 Review.
Cited by
-
Role of mesenchymal stem cells in sepsis and their therapeutic potential in sepsis‑associated myopathy (Review).Int J Mol Med. 2024 Nov;54(5):92. doi: 10.3892/ijmm.2024.5416. Epub 2024 Sep 2. Int J Mol Med. 2024. PMID: 39219272 Free PMC article. Review.
-
Role of Mesenchymal Stem Cells in Counteracting Oxidative Stress-Related Neurodegeneration.Int J Mol Sci. 2020 May 7;21(9):3299. doi: 10.3390/ijms21093299. Int J Mol Sci. 2020. PMID: 32392722 Free PMC article. Review.
-
Exploring Chinese herbal medicine for ischemic stroke: insights into microglia and signaling pathways.Front Pharmacol. 2024 Jan 22;15:1333006. doi: 10.3389/fphar.2024.1333006. eCollection 2024. Front Pharmacol. 2024. PMID: 38318134 Free PMC article. Review.
-
General consensus on multimodal functions and validation analysis of perinatal derivatives for regenerative medicine applications.Front Bioeng Biotechnol. 2022 Oct 3;10:961987. doi: 10.3389/fbioe.2022.961987. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36263355 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources